Skip to main content

ESTUDIO EN PROFUNDIDAD DEL CANALOSOMA CARDIACO DE KV1.5

SAF2016-75021-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2016
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 14
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Fludarabine inhibits Kv1.3 currents in human B lymphocytes

  • Vera-Zambrano, Alba
  • Peraza, Diego A.
  • Valenzuela, Carmen
  • Pérez-Chacón, Gema
  • González, Teresa
Resumen del trabajo presentado al 5th Symposium on Biomedical Research: "Advances and Perspectives In Pharmacology, Drug Toxicity and Pharmacogenetics", celebrado en Madrid del 15 al 16 de marzo de 2018., [Introduction]:Fludarabine (F-ara-A) is a purine analogue commonly used in the treatment of indolent B cell malignancies that interferes with different aspects of DNA and RNA synthesis. KV1.3 potassium channels are membrane proteins involved in the control of K+ homeostasis and in the maintenance of the resting potential of the cell, thus controlling signalling events, proliferation and apoptosis in lymphocytes. The aim of this study was to determine if F-ara-A modulates KV currents in human B lymphocytes. [Material and methods]: We assessed the expression, the activity and the effect of F-ara-A on the KV1.3 channel in BL2 and Dana B cell lines. Currents were registered by whole-cell patch-clamp. Statistical significance was determined by t-Student test or by nonparametric Mann-Whitney test. [Results]: We show that KV1.3 is expressed in both BL2 and Dana B cell lines, although total KV1.3 levels were higher in BL2 compared to those in Dana cells. However, KV currents in the plasma membrane were similar in both cell lines. These KV currents were abrogated by the specific KV1.3 channel inhibitor PAP-1, indicating that most KV currents in these B cell lines are controlled by KV1.3. F-ara-A (3.5 μM), a concentration similar to that achieved in the plasma of fludarabine phosphate-treated patients (3 μM), inhibited KV1.3 currents by 61±6.3% and 52.3±6.3% in BL2 and Dana B cells, respectively. The inhibitory effect of F-ara-A was concentration dependent and showed an IC50 value of 0.36±0.04 μM and a nH value of 1.07±0.15 in BL2 cells and 0.34±0.13 μM (IC50) and 0.77±0.11 (nH) in Dana cells. This inhibitory effect of F-ara-A on the activity of plasma membrane KV1.3 was observed in these cells irrespective of their cytotoxic effect. F-ara-A had no effect on heterologously expressed KV1.3 channels, suggesting an indirect mechanism of inhibition. [Conclusions]: Fludarabine (F-ara-A), a chemotherapeutic drug extensively used in clinics, strongly inhibits KV1.3 currents in B lymphoma and lymphoblastoid cells. Although this inhibitory activity is not sufficient to induce cell death, it might still contribute to the cytotoxic effect of the drug., This study was supported by MINECO (SAF2013-45800-R, SAF2016-75021-R, RD12/0042/0019, CB/11/00222) and ISCIII (PI12/01135 and PI16/00895)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

KV1.3 channel inhibition by indolic compounds in chronic lymphocytic leukemia cells

  • Baena-Nuevo, M.
  • Vera-Zambrano, Alba
  • Martínez-Laperche, Carolina
  • Muñoz-Calleja, Cecilia
  • Buño, Ismael
  • Zapata, Juan M.
  • Pérez-Chacón, Gema
  • González, Teresa
Resumen del trabajo presentado al 5th Symposium on Biomedical Research: "Advances and Perspectives In Pharmacology, Drug Toxicity and Pharmacogenetics", celebrado en Madrid del 15 al 16 de marzo de 2018., [Introduction]: Chronic lymphocytic leukemia (CLL) is the most common leukemia in western countries and it is based on B cell clonal expansion. This disease has no cure and the appearance of pharmacological resistance is very common. We have previously identified indole-3-carbinol (I3C) and its main metabolite, 3,3’-diindolylmethane (DIM), as active compounds with pharmacological activity against CLL. KV1.3 potassium channels are involved in B and T cells function controlling plasmatic membrane potential, Ca2+ entry and cellular proliferation. Therefore, these channels could be a new therapeutic target against CLL. Here, we have analysed if these indolic compounds can act, in part, by modulating the KV1.3 function., [Material and Methods]: we assessed the activity and effect of the indolic compounds on KV1.3 channels in CLL cells that are either sensitive or resistant to I3C cytotoxicity. Currents were registered by whole-cell patch-clamp. Statistical significance was determined by t-Student test or by nonparametric Mann-Whitney test., [Results]: The KV1.3 current magnitude on CLL cells correlated with their sensitivity to the cytotoxic effect of I3C; I3C resistant CLL (IR-CLL) cells exhibiting ≈2.5-fold higher KV1.3 current amplitude than sensitive (IS-CLL) cells. Both I3C and DIM inhibited KV1.3 current in CLL cells, DIM being ≈4-fold more potent than the parent compound. However, a non-cytotoxic compound, indole-3-carboxylic acid (I3CA), did not inhibit the KV1.3 current., [Conclusions]: IR-CLL cells exhibit greater KV1.3 current magnitude than IS-CLL cells, which can be due to the existence of different canalosomes in these cells. The KV1.3 inhibitory effect of the indolic compounds tested, correlates with their cytotoxic effect on CLL cells. Our results suggest that KV1.3 channel could be involved in CLL cells pharmacological resistance mechanisms and its inhibition could be part of the cytotoxic effect of I3C and DIM, which open new venues to the treatment of this disease., This study was supported by MINECO (SAF2013-45800-R, SAF2016-75021-R, RD12/0042/0019, CB/11/00222) and ISCIII (PI12/01135 and PI16/00895)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Effects of n-3, n-6 PUFAs and their derivatives on KV7.1/KCNE1 channels

  • Cruz, Alicia de la
  • Moreno, Cristina
  • Peraza, Diego A.
  • Valenzuela, Carmen
Resumen del trabajo presentado al VI Meeting de la Red Española de Canales Ióniocs (RECI), celebrado en Santiago de Compostela del 6 al 8 de septiembre de 2017., Voltage-dependent potassium channels are spanning-membrane integral proteins involved in several and diverse physiological and pathological processes such as immune response or cardiovascular function. KV7.1 channel with the KCNE1 regulatory subunit form one of the most important current of the repolarization phase of the cardiac action potential (IKs). We analyzed, using the patch-clamp technique, the acute and chronic exposition of polyunsaturated fatty acids (PUFAs), DHA and AA, in KV7.1/KCNE1 channels expressed in COS-7 cells. Acute DHA and AA exposition increased the magnitude of KV7.1/KCNE1 currents. DHA but not AA slowed the activation kinetics. However, both PUFAs accelerated the deactivation kinetics. Chronic exposition to these compounds did not modify the magnitude of the currents. However, DHA shifted the activation curve toward more negative membrane potentials and accelerated the activation and deactivation kinetics of the channels. On the contrary, AA slowed the activation whereas it accelerated the deactivation process. PUFAs effects on KV7.1/KCNE1 channels depends on both the compound’s chemical nature, n-3 or n-6 PUFAs, as well as the time of exposure, which might be acute or chronic. It has been described that enriched PUFAs diet has anti-inflammatory properties. Moreover, n-3 or n-6 PUFAs lipidderived mediators such as lipoxins and resolvins (which levels are increased by the consumption of aspirin), have been emerged as potent anti-inflammatory agents that promote the resolution phase of the inflammation process. Ion channels, and specially potassium ion channels, play an essential role in macrophages physiology. Accordingly, we also studied the lipid-derived mediators effects on both bone marrow derived macrophages (BMDM), which LPSdependent activation are related with the increased of KV1.3/KV1.5 expression, and in KV7.1/KCNE1 channels where the PUFAs effects have been studied. Lipoxins, but not resolvins, could reverse the LPS-activated macrophages. However, resolvins KV7.1/KCNE1 block were much more potent., Funded by SAF2013-45800-R, SAF2016-75021-R, BFU2014-54928-R and CIBERCV (FIS CB/11/00222)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Trabectedin re-educates resting peritoneal macrophages into M1- Subtype

  • Peraza, Diego A.
  • García-Redondo, Ana B.
  • Mojena, Marina
  • Cruz, Alicia de la
  • Briones, Ana M.
  • Boscá, Lisardo
  • Galmarini, Carlos M.
  • Valenzuela, Carmen
Resumen del trabajo presentado al VI Meeting de la Red Española de Canales Ióniocs (RECI), celebrado en Santiago de Compostela del 6 al 8 de septiembre de 2017., Macrophages play an important role in the inflammatory response, acting as antigen-presenting cells and modifying the cytokine milieu and the intensity of T-cell signaling. The electrophysiological properties of macrophages depend on their state of functional activation. Trabectedin induces rapid apoptosis exclusively in mononuclear phagocytes and this effect contributes directly to its antitumor activity. The aim of this study was to evaluate the effects of trabectedin on KV and Kir channels in resident peritoneal and bone marrow-derived macrophages (BMDM) under both short- and long-term incubation with the drug. Experiments were performed using the whole-cell configuration of the patchclamp technique. Following exposure (ca. 10 min) of peritoneal macrophages or BMDM to 100 nM trabectedin neither KV nor Kir were modified. The electrophysiological effects of prolonged treatment with trabectedin were studied after 16 h of incubation with the drug. Under these conditions, trabectedin produced a concentration-dependent effect that was qualitatively similar to the response observed after LPS challenge. Moreover, the increase in KV observed appeared in parallel with a use-dependent decline, typical of macrophages stimulated with LPS. Similarly, the degree of inactivation of the current was greater and faster at higher trabectedin concentrations. All these results suggest that: 1) Trabectedin does not interact with Kir or KV channel. 2) Trabectedin acts by re-educating mouse resting peritoneal macrophages into M1-subtype., Supported by PharmaMar, SAF2016-75021-R and CIBERCV FIS (CB/11/00222) Grants., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

D242N, a KV7.1 LQTS mutation uncovers a key residue for IKs voltage dependence

  • Moreno, Cristina
  • Oliveras, Anna
  • Bartolucci, Chiara
  • Muñoz, Carmen
  • Cruz, Alicia de la
  • Peraza, Diego A.
  • Gimeno, Juan R.
  • Martín-Martínez, Mercedes
  • Severi, Stefano
  • Felipe, Antonio
  • Lambiase, Pier
  • González, Teresa
  • Valenzuela, Carmen
Resumen del trabajo presentado al VI Meeting de la Red Española de Canales Ióniocs (RECI), celebrado en Santiago de Compostela del 6 al 8 de septiembre de 2017., KV7.1 and KCNE1 co-assemble to give rise to the IKs current, one of the most important repolarizing currents of the cardiac action potential. Its relevance is underscored by the identification of more than 500 mutations in KV7.1 and, at least, 36 in KCNE1, that cause Long QT Syndrome (LQTS). The aim of this study was to characterize the biophysical and cellular consequences of the D242N KV7.1 mutation associated with the LQTS. The mutation is located in the S4 transmembrane segment, within the voltage sensor of the KV7.1 channel, disrupting the conserved charge balance of this region. Perforated patch-clamp experiments show that, unexpectedly, the mutation did not disrupt the voltagedependent activation but it removed the inactivation and slowed the activation kinetics of D242N KV7.1 channels. Biotinylation of cell-surface protein and co-immunoprecipitation experiments revealed that neither plasma membrane targeting nor co-assembly between KV7.1 and KCNE1 was altered by the mutation. However, the association of D242N KV7.1 with KCNE1 strongly shifted the voltage dependence of activation to more depolarized potentials (+50mV), hindering IKs current at physiologically relevant membrane potentials. Both functional and computational analysis suggest that the clinical phenotype of the LQTS patients carrying the D242N mutation is due to impaired action potential adaptation to exercise and, in particular, to increase in heart rate. Moreover, our data identify D242 aminoacidic position as a potential residue involved in the KCNE1-mediated regulation of the voltage dependence of activation of the KV7.1 channel., Funded by SAF2013-45800-R, SAF2016-75021-R, BFU2014-54928-R and CIBERCV (FIS CB/11/00222)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Fine-tuning DREAM signaling using chemical tools for neurodegenerative disease treatment

  • Gutiérrez-Rodríguez, Marta
  • Cercós, Pilar
  • Izquierdo García, Carolina
  • Peraza, Diego A.
  • López-Hurtado, Alejandro
  • González Pérez, Paz
  • Dopazo, Xose M.
  • Herranz, Rosario
  • González, Teresa
  • Mellström, Britt
  • Martín-Martínez, Mercedes
  • Naranjo, José Ramón
  • Valenzuela, Carmen
Resumen del trabajo presentado al 6th European Chemical Biology Symposium ECBS/LS-EuChemS, celebrado en Madrid (España) del 3 al 5 de abril de 2019., DREAM (Downstream Regulatory Element Antagonist Modulator), also known as KChIP-3 or calsenilin, is a multifunctional calcium binding protein that controls the expression level and/or the activity of several proteins related to calcium homeostasis, neuronal excitability and neuronal survival. As an auxiliary protein in the plasma membrane, DREAM interacts with, and regulates, the gating of KV4 potassium channels, L- and T-type voltage-dependent calcium channels, NMDA receptors and the transcriptor factor ATF6, which is involved in the unfolding protein response machinary. Considering that altered neuronal calcium homeostasis and the accumulation of poorly folded proteins are common features of many neurodegenerative pathologies, the DREAM modulation could open new avenues for the treatment of neurodegenerative diseases. We recently showed that reduced DREAM expression or blockade of DREAM activity by repaglinide is neuroprotective in Huntington's disease (HD)[1]. However, up to now, only three DREAM binding molecules have been identified. Hence, there is a clear need for the development of chemical tools to modulate and characterize DREAM activity and its interactions. In this communication we will report the identification of novel DREAM modulators by following a multidisciplinary strategy that involves structure-based design, organic chemistry, site-directed mutagenesis and in vitro and in vivo experiments. Our findings open a new avenue in the search of effective treatments of neurodegenerative diseases., Spanish Ministery of Economy, Industry and Competitivity (AEI-FEDER, EU grants): BFU2015-67284-R, SAF2017-89554-R, SAF2016-75021-R, SAF2015-66275-C2-2-R; Instituto de Salud Carlos III CIBERNED and CIBERCV programs; the Madrid regional government/Neurodegmodels; and CSIC PIE 201580E073., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Identification of IQM-266, a novel DREAM ligand that modulates Kv4 currents

  • Peraza, Diego A.
  • Cercós, Pilar
  • Miaja, Pablo
  • Merinero, Yaiza G.
  • Lagartera, Laura
  • Socuéllamos, Paula G.
  • Izquierdo García, Carolina
  • Sánchez, Sara A.
  • López-Hurtado, Alejandro
  • Martín-Martínez, Mercedes
  • Olivos-Oré, Luis Alcides
  • Naranjo, José Ramón
  • Artalejo, Antonio R.
  • Gutiérrez-Rodríguez, Marta
  • Valenzuela, Carmen
Resumen del trabajo presentado al VII Congreso Red Española Canales Iónicos: Symposium 6: Drug Discovery and ion channel Pharmacology, celebrado en Cáceres del 15 al 17 de mayo de 2019., Funded by BFU2015-67284-R (to MG-R), SAF2014-53412-R and SAF2017-89554-R (to JN), SAF2013-45800-R, SAF2016-75021-R (to CV), SAF2015-66275-C2-2-R (to MM-M); UCM grant: PR75/18-21593 (to AA); and CSIC grants: PIE 201820E104 (to CV) and 201880E109 (to MG-R and MM-M)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Remodeling of mice macrophages induced by trabectedin

  • Peraza, Diego A.
  • Povo-Retana, Adrián
  • Boscá, Lisardo
  • Galmarini, Carlos M.
  • Valenzuela, Carmen
Resumen del trabajo presentado al VII Congreso Red Española Canales Iónicos, celebrado en Cáceres del 15 al 17 de mayo de 2019., Immune cells have an important role in the tumor-microenvironment. Macrophages may tune the immune response toward inflammatory or tolerance pathways. Tumor associated macrophages (TAM) have immunosuppressive functions and they are considered a therapeutic target in cancer. The aim of this study was to evaluate the effects of trabectedin, a new class of antitumor agent, on the tumor-microenvironment through the study of electrophysiological and molecular phenotype of macrophages. Experiments were performed using the whole-cell patchclamp configuration of the patch-clamp technique in resident peritoneal mouse macrophages under different types of polarization. Trabectedin decreased macrophages viability and increased ROS production. Trabectedin does not directly interact with KV1.5 and KV1.3 channels, but treatment (16h) of macrophages with sub-cytotoxic concentrations (0.1-5 nM) increased their KV current in a concentration-dependent manner due to an upregulation of KV1.3 channels. In vitro generated TAM (TAMiv), by a co-culture of ID8 cells and macrophages, exhibited a M2 phenotype. TAMiv generated a small KV current, similarly to M2 polarized macrophages, and expressed high levels of M2 markers. In this study, we demonstrated that TAMiv polarization could be re-educated by using sub-cytotoxic concentration of trabectedin. TAMiv treated with sub-cytotoxic concentrations of trabectedin exhibited an upregulation of KV1.3 channels and their M2 phenotype changed towards M1 pro-inflammatory one., Funded by PharmaMar, CSIC 201820E104, CIBERCV and SAF2016-75021-R., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Electrophysiological effects of IQM-266 on KV1.5 channels

  • Benito-Bueno, Ángela de
  • Socuéllamos, Paula G.
  • Cercós, Pilar
  • Sánchez, Sara A.
  • Peraza, Diego A.
  • Gutiérrez-Rodríguez, Marta
  • Valenzuela, Carmen
Resumen del trabajo presentado al VII Congreso Red Española Canales Iónicos, celebrado en Cáceres del 15 al 17 de mayo de 2019., The outward potassium current IKur is the main responsible of the atrial repolarization process and it is generated by the activation of KV1.5 channels, widely expressed in human atria. It is known that mutations in KCNA5 gene, which induce both gain- and loss-of-function in KV1.5 channel, enhance atrial fibrillation susceptibility. Thus, these channels represent a pharmacological target for the development of antiarrhythmic drugs useful in the treatment of supraventricular arrhythmias. KV1.5 channels assembly with several regulatory subunits such as KVβ and KChIPs (KV Channel Interacting Proteins). It has been described that KChIP2 physically interacts with KV1.5 and reduces KV1.5 cell surface expression levels. Our research group has demonstrated that IQM-266 inhibits the current generated by the activation of KV4.3 and KV4.3/KChIP2, being the effects more marked when KChIP2 is present. The aim of the present study is to analyze the effects of IQM-266 on KV1.5 channels. In order to achieve these objectives, HEK293 cells transiently expressing KV1.5 were used. Currents were recorded using the whole-cell configuration of the patch-clamp technique. The effects of IQM-266 on KV1.5 currents were concentration-dependent with an IC50 of 11 μM (n=24). Block induced by IQM-266 (20 μM) sharply increased within the membrane voltage range of the channel activation, arising a maximum degree of block at +20 mV that remained constant at more positive membrane potentials. This compound at 20 μM produced a timedependent block, inducing a: 1) faster inactivation (τ = 305.8±47.6 ms vs. 168.0±13.4 ms, in the absence and in the presence of IQM-266, respectively, n=9, p<0.01), and 2) slower deactivation kinetics, increasing the contribution of the slow component of deactivation to the total process (0.36±0.05 vs. 0.57±0.05, in the absence and in the presence of IQM-266, respectively, n=11, p<0.01). These results are consistent with an open channel block mechanism. Finally, IQM-266 (20 μM) enhanced the degree of use-dependent block of the current (25.6±2.7% vs. 77.6±4.9%, in the absence and in the presence of IQM-266, n=5, p<0.001). These phenomenon was explained by a slowing of the recovery process in the presence of the compound (991.1±131.8 ms vs. 5132.8±763.6 ms in the absence and in the presence of IQM-266, respectively, n=4, p<0.05). Thus, IQM-266 is able to bind KV1.5 channels, although with less affinity than that shown in KV4.3/KChIP2 complexes., Supported by SAF2016-75021-R and CSIC PIE201820E104 to CV, BFU2015-67284-R and CSIC PIE201880E109 to MGR., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

IQM-PC332, a novel DREAM ligand with analgesic effect on experimental peripheral nerve injury- and diabetes-induced pain

  • Socuéllamos, Paula G.
  • Cercós, Pilar
  • Olivos-Oré, Luis Alcides
  • Barahona, María Victoria
  • Bosch, Gerardo
  • Naranjo, José Ramón
  • Valenzuela, Carmen
  • Gutiérrez-Rodríguez, Marta
  • Artalejo, Antonio R.
Resumen del trabajo presentado al VII Congreso Red Española Canales Iónicos, celebrado en Cáceres del 15 al 17 de mayo de 2019., Neuropathic pain is a form of chronic pain arising from damage to the nerves that sense, transmit or process information about environmental stimuli. Given its growing prevalence and common refractoriness to conventional analgesics, the development of new drugs with pain relief effect constitute a prominent clinical need. In this respect, drugs that reduce activity of sensory neurons by modulating ion channels hold the promise to become effective analgesics. Here we have used two models of neuropathic pain, namely the chronic constriction injury of the sciatic nerve (CCI) and the streptozotocin-induced diabetic neuropathy, to evaluate the mechanical antiallodynic effect of IQM-PC332, a novel Downstream Regulatory Element Antagonist Modulator (DREAM)/KChIP3/calsenilin ligand potentially affecting DREAM modulated ionic currents like potassium IA and ICav. IQM-PC332 exerted a mechanical antiallodynic effect following intraperitoneal (I.P; DE50 of 0.06 μg/kg, Emax of 65%) and intraplantar (DE50 of 0.24 mg, Emax of 68%) administration in the CCI, model. Likewise, IQM-PC332 2 μg/kg I.P. significantly reduced mechanical allodynia in diabetic animals. Interestingly, no effect of IQM-PC332 on glucose levels from both CCI and diabetic animal could be observed at analgesic doses. The effects of IQM-PC332 on INav, ICav, IA, and the electrical excitability in neurons isolated from dorsal root ganglia (L4-L6; DRG) were also studied with the patch-clamp technique. IQM-PC332 reduced peak amplitudes of ICav from both Control and CCI animals with CI50 (@ +10 mV) of 78 μM y 40 μM, respectively. At variance, IQM-PC332 did not exert any effect on INav in the concentration range from 0.01 to 50 μM. PC332 10 μM also inhibited IA in DRG neurons from CCI animals, this effect being larger with membrane depolarization (≈ 50% inhibition at -10 mV). Interestingly, in about 55% of the neurons, IQM-PC332 slowed inactivation of IA. In accordance with its effects on ion currents, IQM-PC332 10 μM reduced the time to the first action potential (AP) evoked by current injection while decreasing the amplitude and duration of the after hyperpolarization that followed after APs within a train. However, no clear effect on instantaneous frequency of AP could be observed. It is suggested that inhibition of Ca2+ entry through Cav channels coupled to neurotransmitter release from peripheral and central terminals of nociceptive neurons may underlie the analgesic effect of IQM-PC332., Supported by Universidad Complutense, grant PR75/18-21593 to ARA, SAF2016-75021-R and PIE201820E104 to CV, BFU2015-67284-R and PIE201880E109 (CSIC grant) to MGR., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Re-education of tumor associated macrophages by trabectedin

  • Peraza, Diego A.
  • García-Redondo, Ana B.
  • Povo-Retana, Adrián
  • Arias, Sara
  • Briones, Ana M.
  • Boscá, Lisardo
  • Galmarini, Carlos M.
  • Valenzuela, Carmen
Resumen del trabajo presentado al 63rd Annual Meeting Biophysical Society, celebrado en Baltimore, Maryland (USA) del 2 al 6 de marzo de 2019., Immune cells have an important role in the tumor-microenvironment. Macrophages may tune the immune response toward inflammatory or tolerance pathways. Tumor associated macrophages (TAM) have immunosuppressive functions and they are considered a therapeutic target in cancer. The aim of this study was to evaluate the effects of trabectedin, a new class of antitumor agent, on the tumor-microenvironment through the study of electrophysiological and molecular phenotype of macrophages. Experiments were performed using the whole-cell configuration of the patch-clamp technique in resident peritoneal mouse macrophages under different types of polarization. Trabectedin decreased macrophage viability and increased ROS production. Trabectedin does not directly interact with KV1.5 and KV1.3 channels, but treatment (16 h) of macrophages with sub-cytotoxic concentrations (0.1-5 nM) increased their KV current in a concentration-dependent manner due to an upregulation of KV1.3 channels. In vitro generated TAM (TAMiv), by a co-culture of ID8 cells and macrophages, exhibited a M2 phenotype. TAMiv generated a small KV current, similarly to M2 polarized macrophages, and expressed high levels of M2 markers. In this study, we demonstrated that TAMiv polarization could be re-educated by using sub-cytotoxic concentration of trabectedin. TAMiv treated with sub-cytotoxic concentration of trabectedin exhibited an upregulation of KV1.3 channels and their M2 phenotype changed towards M1 pro-inflammatory one., Funded by PharmaMar, CSIC 201820E104, CIBERCV and SAF2016-75021-R., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Effects of IQM-110 on Kv1.5/Kvß2.1 channels

  • Valencia, María
  • Benito-Bueno, Ángela de
  • Socuéllamos, Paula G.
  • Bonache de Marcos, María Ángeles
  • Viedma, Carmen
  • Martín-Martínez, Mercedes
  • Gutiérrez-Rodríguez, Marta
  • Valenzuela, Carmen
Resumen del trabajo presentado en el VIII Congreso Red Española de Canales Sónicos, celebrado en Alicante (España) del 24 al 27 de mayo de 2022., The outward potassium current IKur is the main responsible of the atrial repolarization process and it is generated by the activation of KV1.5 channels, widely expressed in human atria. It is known that mutations in KCNA5 gene, which induce both gain- and loss-of-function in KV1.5 channel, enhance atrial fibrillation susceptibility. Thus, these channels represent a pharmacological target for the development of antiarrhythmic drugs useful in the treatment of supraventricular arrhythmias. KV1.5 channels assembly with several regulatory subunits such as KVß. It has been described that KVß2.1 interacts with KV1.5. Our research group has demonstrated that the molecule IQM-110 produces electrophysiological effects on the KV1.5. The aim of the present study is to analyze the electrophysiological effects of IQM-110 on KV1.5 channels when it was expressed together with the regulatory subunit KVß2.1. In order to achieve this objective, Ltk- cell line constitutively expressing KVß2.1 and with an induced expression of KV1.5 were used. Currents were recorded using the whole-cell configuration of the patch-clamp technique. The effects of IQM-110 on KV1.5/Kvß2.1 current were concentration-dependent with an IC50 of 166¿M (n=64). This compound at 100¿M produced a time-dependent block, inducing a: 1) faster activation (¿=2.8±0.3 vs. 4.1±0.3 ms, n=10, p<0.01), 2) faster inactivation reducing the slow time constant, (¿slow=3172.6±113.8 vs. 629.1±43.8ms, n=5, p<0.001), and 3) slower deactivation kinetics, (¿slow=73.5±3.5 vs. 115.2±12.1ms and ¿fast=19.5±1.3 vs. 27.9±1.9ms, n=10, p<0.01 and p<0.5 respectively). These results are consistent with an open channel block mechanism. Finally, IQM-110 (100 ¿M) enhanced the degree of use-dependent block of the current (1.7±0.4 vs. 47.7±2.4%, n=5, p<0.001). This phenomenon was explained by a slowing of the recovery process in the presence of IQM-110 (¿r=462.6±94.9 vs. 3545.0±254.1ms, n=5, p<0.001). In summary, IQM-110 modulates KV1.5/KVß2.1 channels consistent with an open channel block mechanism., Funded by: Grants SAF2016-75021-R, RTI2018-097189-B-C22 funded by MCIN/AEI/10.13039/501100011033 and by ¿ERDF A way of making Europe¿; Grants PID2019-104366RB-C21, PID2019-104366RB-C22, PID2020-113238RB-I00 funded by MCIN/AEI/ 10.13039/501100011033; Grant CB/11/00222 funded by ISCIII CIBERCV; Grants PIE202180E073 and 2019AEP148 funded by CSIC. Grants BES-2017-080184, PRE-2020-093950, BES-2010-036573 and FPU17/02731 funded by MCIN/AEI/ 10.13039/501100011033 and by ¿ESF Investing in your future.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Electrophysiological effects of IQM-266 on Itof. Role of cardiac beta subunits

  • Benito-Bueno, Ángela de
  • Socuéllamos, Paula G.
  • Cercós, Pilar
  • Izquierdo García, Carolina
  • Martín-Martínez, Mercedes
  • Delgado, Carmen
  • Gutiérrez-Rodríguez, Marta
  • Valenzuela, Carmen
Trabajo presentado en el VIII Congreso Red Española de Canales Sónicos, celebrado en Alicante (España) del 24 al 27 de mayo de 2022., The transient outward potassium current (Itof), responsible for the repolarization of cardiac action potential, is generated by the activation of KV4 channels assembled with KChIP2 and other accessory subunits, such as DPP6 and KCNE2. To test the hypothesis that these subunits modify 18 VIII Congreso Red Española de Canales Iónicos the pharmacological response of the channel, we have analyzed the electrophysiological efects of IQM-266 on the currents generated by KV4.3/KChIP2, KV4.3/KChIP2/DPP6, KV4.3/KChIP2/KCNE2 channels and on the total I K and I tof in cardiac myocytes. CHO cells were transiently transfected (KV4.3/KChIP2, KV4.3/KChIP2/DPP6 or KV4.3/KChIP2/KCNE2), and the potassium currents were recorded using the whole-cell patch-clamp technique. In mice cardiac myocytes, potassium currents were recorded by using the perforated patch-clamp technique. Our results indicate that IQM-266 exerts an activating efect on the I K and I tof peak amplitude in cardiac myocytes. To decipher whichbeta subunits were involved in these efects, IQM-266 was studied in CHO cells transfected with the above-mentioned cDNAs. IQM-266, at 3 μM, induced an increase in the KV4.3/KChIP2 current charge, which augmented in the presence of DPP6, whereas it was abolished when KCNE2 was expressed. However, IQM-266 decreased the peak amplitude in transfected cells. In this study we concluded that: i) IQM-266 is a new activator of the I tof in mice cardiac myocytes, ii) DPP6 and KCNE2 modify the pharmacological response of KV4.3/KChIP2 channels to IQM-266, and iii) the presence of either DPP6 or KCNE2 is not enough to reproduce the activator efect observed when IQM-266 was tested on Ito recorded from mouse ventricular myocytes., Grants SAF2016-75021-R, RTI2018-097189-B-C22 funded by MCIN/AEI/10.13039/501100011033 and by ¿ERDF A way of making Europe¿; Grants PID2019-104366RB-C21, PID2019-104366RB-C22, PID2020-113238RB-I00 funded by MCIN/AEI/ 10.13039/501100011033; Grant CB/11/00222 funded by ISCIII CIBERCV; Grants PIE202180E073 and 2019AEP148 funded by CSIC. Grants BES-2017-080184, BES-2010-036573 and FPU17/02731 funded by MCIN/AEI/10.13039/501100011033 and by ¿ESF Investing in your future¿.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

IQM-110, a new selective inhibitor of KChIP and its pharmacological effects on Kv4., Kv4./KChIP and Kv4./KChIP currents

  • Benito-Bueno, Ángela de
  • Bonache de Marcos, María Ángeles
  • Viedma, Carmen
  • Martín-Martínez, Mercedes
  • Gutiérrez-Rodríguez, Marta
  • Valenzuela, Carmen
Trabajo presentado en el VIII Congreso Red Española de Canales iónicos, celebrado en Alicante (España) del 24 al 27 de mayo de 2022., Kv4 channels generate outward currents activated at subthreshold membrane potentials and are responsible for the repolarization of both cardiac and neuronal action potentials through ITO (transient outward current) and IA (A-type K+ current), respectively. Kv4 dysfunctions have been identified in cardiac diseases (i.e. Brugada syndrome or atrial fibrillation) as well as in neuronal diseases (i.e. schizophrenia, epilepsy or Alzheimer’s disease). However, Kv4 channels need to assemble with regulatory or β subunits to fully reproduce ITO and IA currents. Among them, we will focus on KChIPs (potassium channel interacting proteins), being KChIP3 predominant in the brain and KChIP2 in both brain and heart. The assembly of these β subunits alters not only the biophysical properties of the channel, but also its pharmacology. For this reason, we have analysed the electrophysiological effects of IQM-22110 (a new compound designed to bind KChIP3) on the currents generated by Kv4.3, Kv4.3/KChIP2 and Kv4.3/KChIP3 channels. CHO cells were transiently transfected (Kv4.3, Kv4.3/KChIP2 or Kv4.3/KChIP3), and the potassium currents were recorded using the whole-cell patch-clamp technique. Our results indicate that IQM-22110 exerts differential effects on Kv4.3, Kv4.3/KChIP2 and Kv4.3/KChIP3 currents. First of all, the concentration-dependence of inhibition was modified, being the IC50 = 5.5 μM for Kv4.3 channels, 10.4 μM for Kv4.3/KChIP2 and exhibited a biphasic curve when KChIP3 is present (IC50(1) = 0.03 μM and IC50(2) = 26.3 μM), suggesting two binding sites for IQM-22110 in this complex. With molecular dynamics and sitedirected mutagenesis, we have identified two aminoacids (Y130 and K166) in KChIP3 critical to the binding of IQM-22110 to its high affinity site. Also, we selected equipotent concentrations of IQM22110 to further study the biophysical effects of this compound on each situation, demonstrating that IQM-22110 binds to the closed-active state of the channel. In this study we concluded that: i) at low concentrations, IQM-22110 is a selective inhibitor of Kv4.3/KChIP3, ii) Y130 and K166 in KChIP3 are critical to the binding of IQM-22110 to the high affinity site in Kv4.3/KChIP3, and iii) IQM-22110 binds to the closed-active state of Kv4.3, Kv4.3/KChIP2 and Kv4.3/KChIP3., Funded by SAF2016-75021-R; PID2019-104366RB-C21, PID2019-104366RB-C22, PID2020-114256RB-I00 and PID2020-119805RB-I00 grants funded by MCIN/AEI/10.13039/501100011033; PIE201820E104, CSIC2019AEP148, PIE202180E073 and 2019AEP148 funded by CSIC; CIBER CB/11/00222. PGS holds an FPU grant (FPU17/02731) funded by Ministerio de Universidades. AB-B holds BES-2017-080184 FPI grant funded by MCIN/AEI/ 10.13039/501100011033 and by “ESF Investing in your future”. C.V.B. holds PRE2020-093542 FPI grant funded by MCIN/AEI/10.13039/501100011033.